Table 5.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Hazard ratio (95%CI) | P‐value | Hazard ratio (95%CI) | P‐value | |
Age | 1.084 (1.031–1.494) | 0.0007 | 1.089 (1.032–1.155) | 0.0009 |
Male sex | 0.914 (0.366–2.315) | 0.8459 | n.a. | |
Coronary artery disease | 3.061 (1.233–7.949) | 0.0162 | 2.934 (1.175–7.678) | 0.0214 |
Atrial fibrillation | 1.024 (0.396–2.534) | 0.9597 | n.a. | |
Left ventricular ejection fraction | 1.000 (0.973–1.028) | 0.9992 | n.a. | |
B‐type natriuretic peptide | 0.428 (0.999–1.000) | 0.6666 | n.a. | |
Estimated GFR | 0.987 (0.966–1.009) | 0.2430 | n.a. | |
Peripheral arterial disease | 3.290 (0.511–12.076) | 0.1765 | n.a. | |
Lung disease | 4.387 (0.974–14.573) | 0.0535 | n.a. |
CI, confidence interval; GFR, glomerular filtration rate; n.a., not applicable.